Women's Health
Comprehensive Diagnostic Pathology and Pathogen Detection
Diagnostic Support for Women’s Health Providers
QDx pathologists are your diagnostic partners in the diagnosis, prognosis and monitoring of gynecologic pathology including breast, hysterectomies, POC, biopsies, as well as sexual health – including sexually transmitted infections (STIs) testing for both women and men.
QDx pathologists provide pathology examinations and interpretations of GYN tissue samples utilizing special stains and select IHC stains. If necessary, our pathologists provide personalized consultations to the referring provider.
GYN Anatomic Pathology Consultations:
- Hysterectomy
- Uterine
- Products of Conception
- Cervicovaginal
- Endometrial
- FNA
QDx offers the Hologic Thin Prep PAP test collection system which enables multiple testing options from a single vial including PAP, HPV and CT/GC. QDx recommends co-testing, PAP + HPV, as the primary screening method for cervical cancer.
Turn Around Time – 72 hours
PAP, Liquid Based
PAP with HPV Co-testing
PAP + HPV + CT/GC
PAP with HPV reflex – ASCUS
PAP with HPV reflex – ASCUS + CT/GC
The QDx vaginitis testing options detect the three most common causes of infectious vaginitis – bacterial vaginosis, candida vaginitis and trichomoniasis.¹ All our vaginitis assays offer the convenience of a single swab collection and the accuracy of PCR testing methodology. Test panels are configured for a targeted approach to utilizing clinically appropriate tests.
- Aptima® Bacterial Vaginosis
- Aptima® Bacterial Vaginosis Expanded
- BD Affirm™ Vaginitis
- Candida & Trichomonas Assay
- Mycoplasma genitalium
- Trichomonas vaginalis
Source: 1. https://www.nichd.nih.gov/health/topics/vaginitis/conditioninfo/causes
QDx UTI pathogen panel is a PCR assay for the detection of microorganisms commonly associated with urinary tract infections. The assay also detects the presence of the most common antibiotic resistant genes.
QDx HPV testing provides detection of human papillomavirus E6/E7 mRNA, histological localization of HPV within the tissue, and differentiation of low-risk vs. high-risk subtypes in formalin-fixed paraffin-embedded tissues.
Turn Around Time: 48 hours
SEXUALLY TRANSMITTED INFECTIONS (STIs)
According to the CDC, 1 in 5 people in the US have an STI. ¹ New infections, both diagnosed and undiagnosed, are estimated at 13M for human papillomavirus (HPV), 6.9M for Trichomoniasis, 4M for Chlamydia, 1.6M for Gonorrhea, and 572K for herpes simplex virus type 2 (HSV-2).¹ Chlamydia, trichomoniasis, genital herpes, and HPV accounted for 98% of all prevalent STIs and 93% of all new STIs in 2018.¹ For guidance, the CDC’s updated 2021 STI screening recommendations may be found on their website. QDx Pathology uses nucleic acid amplification (NAA)-based assays to detect and differentiate pathogen RNA, allowing for rapid and reliable test results.
- CT/NG
- HPV with Reflex to Genotyping for 16, 18/45 if HPV+
- HSV 1&2
- Mycoplasma Genitalium
- Trichomonas Vaginalis
Source: 1. https://www.cdc.gov/std/statistics/prevalence-2020-at-a-glance.htm
